Vitalant Research Institute

What Vitalant Research Institute does

Vitalant Research Institute (VRI) is a nonprofit transfusion medicine research organization operating as a wholly aligned subsidiary of Vitalant, a national network of blood centers. Founded in 1959 in San Francisco and rebranded under its current name in 2018, VRI runs one of the largest transfusion research programs based in blood centers in the United States, with operations in San Francisco and Denver. Its work is structured around six research areas (Infectious Diseases, Blood Donors and Health, Transfusion Immunology, Transfusion Outcomes, Cellular Therapies and Models, and Blood Components) supported by six specialized cores (Bioinformatics, Cell Therapy, Epidemiology, Immunology, Molecular Technology and Genomics, and Research Operations) that provide end-to-end capabilities from protocol development and biospecimen collection through sequencing, immunoassays, cell sorting, and biostatistics.

The institute's underlying technology assets include next-generation sequencing pipelines on Illumina and Oxford Nanopore platforms, single-copy HIV RNA assays, ultrasensitive pathogen detection, spectral flow cytometry (Cytek Aurora), multiplex immunoassays (Luminex, MSD), and a computing footprint of more than 300 CPUs, 2 TB of RAM, and 100 TB of storage. Its primary data differentiator is a set of vein-to-vein databases linking donor characteristics, blood component processing, and recipient electronic health records. The Vitalant Innovation Center (Denver, 2021) and Cell Sourcing business (catalog RE103-RE901) provide translational and fee-for-service capabilities including custom research blood collection, clinical trial manufacturing, and device beta-testing.

VRI's revenue model is a hybrid of grant funding (NHLBI REDS/REDS-IV-P central laboratory, Bill and Melinda Gates Foundation RAVEN, FDA TTIMS), commercial cell sourcing (quote-based unit pricing for research-grade blood products), philanthropic donations (including the Vitalant Foundation's $1 million Busch First Response Fund), and Innovation Center service fees. Customer segments span academic and research institutions, pharmaceutical and biotech companies, diagnostic laboratories, area hospitals, and federal regulators (FDA, CDC, NIH), with the parent Vitalant network providing unique donor and specimen access. The institute holds academic affiliations with UCSF through dual investigator appointments and offers postdoctoral and fellowship training programs.

Name

Vitalant Research Institute

Legal name

Vitalant Research Institute

Website

https://research.vitalant.org

Company type

Private

Founded year

1959

Operating status

Operating

Headcount range

101–250 employees

Short description

Vitalant Research Institute is a nonprofit transfusion medicine research organization and subsidiary of Vitalant, conducting blood safety, infectious disease, and cellular therapy research across six specialized cores in San Francisco and Denver, funded by federal grants, fee-for-service cell sourcing, and philanthropy.

Ownership category

akta.pro rank

Product category

Transfusion Medicine Research Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Blood and Organ Banks (621991), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Industry & Sector Research (Syndicated/Custom) (BPAHALAE)

Keywords

• Transfusion medicine research
• Blood safety research
• Research blood products
• Cellular therapy research
• Infectious disease surveillance

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Grant Funding: The institute operates primarily as a non-profit research organization funded through external grants from organizations such as the National Heart, Lung, and Blood Institute (NHLBI), the Bill and Melinda Gates Foundation, and other federal and private research funders.
2. Cell Sourcing Products and Services: Sale of blood-derived research products and services including whole blood, red blood cells, plasma, platelets, white blood cells, and custom products to researchers, diagnostic laboratories, and pharmaceutical and biotech companies.
3. Donations and Philanthropy: Financial support from donors and the Vitalant Foundation, including the Dr. Michael P. Busch First Response Fund campaign.
4. Vitalant Innovation Center Services: Fees for custom research blood collection, clinical trial manufacturing, blood processing, beta-testing of collection and processing systems, pre-clinical testing, assay development and validation, equipment evaluation, and bacterial testing.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Vitalant Research Institute is a nonprofit research organization that conducts scientific and policy research in transfusion medicine, infectious disease, immunology, and cellular therapies. It sells customizable research-grade blood components (whole blood, red cells, plasma, platelets, leukopaks) and provides contracted research services, biorepository access, and biospecimen testing through six specialized cores and the Vitalant Innovation Center.

Product overview

Vitalant Research Institute is a nonprofit research organization (not a software company) offering a portfolio of six interconnected research programs focused on blood safety and transfusion medicine: Infectious Diseases Research, Blood Donors and Health Research, Transfusion Immunology Research, Transfusion Outcomes Research, Cellular Therapies and Models Research, and Blood Components Research. These programs are supported by six specialized research cores (Bioinformatics, Cell Therapy, Epidemiology, Immunology, Molecular Technology and Genomics, and Research Operations) that provide shared services. Additional offerings include the Vitalant Innovation Center for product development, Cell Sourcing Products & Services for custom blood components, Blood Donation for Research, and Postdoctoral & Research Training programs. The organization operates FDA-registered donor centers in Denver, Colorado and San Francisco, California.

Differentiator

Problem solved

Functional benefit

Brands

• Vitalant Innovation Center: Innovation center developing products and services for Vitalant and external partners, with dedicated research donor collection facility and laboratory.

Products and services

• Infectious Diseases Research

Quantifiable outcome

• Over 200 publications authored by key investigators
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, major, strategic and supporting.

• University of California, San Francisco (UCSF)coreStrategic or Co-development PartnerVitalant Research Institute maintains a close affiliation with UCSF through dual appointments for investigators, coursework and training opportunities for postdoctoral trainees, and collaborative research programs. Many VRI investigators hold academic positions at UCSF including the Department of Laboratory Medicine, Department of Pathology, and Department of Medicine.
• U.S. Food and Drug Administration (FDA)majorStrategic or Co-development PartnerVRI collaborates with the FDA on blood safety policy, screening guidelines, and donor deferral policies. Brian Custer serves as principal investigator of the Laboratory and Risk Factor Coordinating Center of the Transfusion-Transmitted Infections Monitoring System (TTIMS) funded by FDA.
• Centers for Disease Control and Prevention (CDC)majorStrategic or Co-development PartnerVRI collaborates with CDC on infectious disease surveillance, including Zika virus research, SARS-CoV-2 serosurveillance, and other emerging pathogen monitoring. Samples are distributed to CDC for assay development.
• Cerus CorporationstrategicStrategic or Co-development PartnerMarion Lanteri serves as Director Scientific Affairs at Cerus Corporation while maintaining an affiliate investigator position at VRI. Collaborates on ongoing research with REDS-III investigators on Zika virus persistence and red blood cell storage lesion through the RBC-Omics project.
• Vitalant (parent organization)coreStrategic or Co-development PartnerVRI operates as part of Vitalant, a national network of blood centers and donor testing laboratories. This provides unique access to blood donors and clinical specimens for research. VP Michael Busch is also vice president for research at Vitalant.
• Brazilian Transfusion Safety Research ProgramsmajorStrategic or Co-development PartnerVRI collaborates with Brazilian institutions through the REDS-IV-P Brazil Transfusion Safety Research Program, including studies with sickle cell disease cohorts and collaboration with the University of Sao Paulo Institute of Tropical Medicine led by Dr. Ester Sabino.
• South African National Blood ServicemajorStrategic or Co-development PartnerVRI collaborates with South African National Blood Service on HIV research and blood donation policy studies, including qualitative studies on blood donations by people living with HIV on antiretrovirals.
• University of Sao PaulomajorStrategic or Co-development PartnerThrough Dr. Ester Sabino, VRI collaborates with the University of Sao Paulo's Institute of Tropical Medicine and Department of Infectious Disease on blood-borne infectious diseases, HIV diversity, Chagas disease, and sickle cell disease research.
• Creative Testing SolutionssupportingStrategic or Co-development PartnerThe Epidemiology Core supports research and operational initiatives requiring expertise in epidemiology, statistics, and machine learning across Vitalant Research Institute, Vitalant, Creative Testing Solutions, and other collaborators.

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

Emerging players

• Cerus Corporation: A publicly traded biotech focused on pathogen reduction technologies for blood components. Directly comparable to VRI's Innovation Center work on blood component safety, and is an explicit partner via VRI affiliate investigator Marion Lanteri.

Regional players

• Héma-Québec: Québec's provincial blood operator with internal research activity on transfusion safety and donor epidemiology. Comparable to VRI in mandate and embedded-in-blood-center model, but operates in a different (Canadian) regulatory and donor market.
• Canadian Blood Services Research: Canada's national blood operator with a research and development arm covering transfusion medicine and donor health. Comparable institutional model and research scope but serves a different national donor population than VRI.
• NHS Blood and Transplant Research: The research arm of the U.K.'s national health service blood and transplant authority. Directly comparable in mission (transfusion safety, donor epidemiology, cellular therapies) but operates under the NHS in a distinct regulatory environment.

Broad incumbents

• Terumo BCT: A global medical device company focused on blood component collection, processing, and cellular therapy manufacturing. Comparable to VRI's Innovation Center work on blood component technology; VP Susanne Marschner moved to VRI from Terumo BCT, signaling strong ties between the two organizations.
• Grifols (Diagnostic and Blood Screening Division): A global diagnostics and blood plasma products company that operates donor screening laboratories and develops transfusion-transmitted infection assays. Comparable as a commercial player in blood safety diagnostics, but operates at much larger scale and is a customer of VRI's research services rather than a peer in fundamental research.
• American Red Cross Blood Services Research: The American Red Cross operates the largest U.S. blood collection network with an internal research program on transfusion medicine. Comparable as a blood-bank-sponsored research entity, but VRI is significantly more specialized in transfusion-transmitted infectious disease and epidemiology than the broader Red Cross research footprint.

Direct peers

• Lindsley F. Kimball Research Institute (New York Blood Center Enterprises): The research arm of New York Blood Center Enterprises, one of the other significant U.S. blood center-sponsored research programs. Directly comparable to VRI in scope (transfusion medicine, infectious disease, cellular therapy) and institutional model (non-profit, embedded in a large blood center network).
• Bloodworks Northwest Research Institute: The research institute of Bloodworks Northwest, a Pacific Northwest blood center. Operates with a similar model of non-profit transfusion medicine and blood safety research embedded in a regional blood bank, with comparable grant-funded programs and core laboratory services.
• Creative Testing Solutions: A blood donor testing laboratory that partners with VRI's Epidemiology Core and shares exposure to U.S. donor screening and transfusion safety research. Closely comparable in operational niche (donor testing, epidemiology support) and is an explicit partner of VRI per disclosed materials.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vitalantorg

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitalant Research Institute